Cowealth Group

Cowealth Group is the only medical company currently listed in Taiwan and mainland China. The subsidiary, Cowealth Medical Holdings Co., Ltd., is listed on the Taipei Exchange (stock symbol: Cowealth KY; stock code: 4745), while Cowealth Medical China Co., Ltd. is listed on the main board of the Shanghai Stock Exchange (stock symbol: Cowealth China; stock code: 603122).

Shanghai became the operations headquarters of Cowealth in 2000. The company's founding mission is to elevate healthcare standards in Greater China, with the vision of equipping all hospitals with top-notch medical equipment and enabling the vast majority of people to have access to cutting-edge medical technologies. Since its inception, Cowealth has been committed to building a system of high-quality healthcare services and promoting the growth of the larger healthcare sector. We aim to make hospitals more competitive by introducing new technologies and service models. Cowealth is committed to being a versatile service supplier offering comprehensive services and making a distinctive impact.

Through dual innovation in technology and service models, Cowealth has introduced various solutions in line with the national requirements for high-quality development in hospitals. Our wide range of solutions include refined management services tailored specifically for in-vitro diagnostic reagents and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. By implementing these digital and intelligent solutions, Cowealth can empower hospitals to operate more efficiently and deliver high-quality care to their patients.

Cowealth Group’s Chairperson, Ms. Wang Qiongzhi, actively supports collaboration in the healthcare sector between mainland China and Taiwan. In 2023, she held prominent positions as both Vice President of the Association of Taiwan Investment Enterprises on the Mainland (ATIEM) and Chairperson of the Big Health Industry Working Committee at both the Shanghai Taiwan Investors Association and the Tianjin Taiwan Investors Association. Through these roles, Ms. Wang played a key role in facilitating the participation of Taiwanese companies in the development of the mainland's healthcare industry.

Cowealth has always been committed to promoting medical exchanges between both sides of the Taiwan Strait. For over two decades, this commitment has served as a valuable bridge, facilitating the sharing of Taiwan's healthcare successes with mainland hospitals and strengthening the education and development of skilled professionals in the field. The company’s cross-Strait exchange platform is widely recognized for its high-level engagement, diverse topics, and geographical diversity. It has enabled constructive dialogues between high-level officials on both sides, covering topics such as government healthcare systems, hospital management best practices, cross-disciplinary collaboration, talent recruitment, and training programs for physicians and nursing professionals. To date, over 50,000 individuals across 110 mainland cities have connected and collaborated through this platform.

Moving forward, Cowealth remains committed to long-term growth in the medical product distribution sector. By advocating transparent business practices and empowering hospital management and development, we strive for healthcare excellence together. Cowealth has achieved great success over the years thanks to the unwavering trust and encouragement of our clients. Building upon this solid foundation, we aspire to become the leading healthcare distributor in the Chinese-speaking market. Our commitment remains strong as we strive to ascend as a prominent rising star in the dynamic realm of medical technology.